Cargando…

One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis

BACKGROUND/AIMS: To evaluate the efficacy and safety of the PreserFlo MicroShunt glaucoma device in a multicentre cohort study. METHODS: All consecutive patients who received the microshunt with mitomycin-C (MMC) 0.4 mg/mL from May 2019 to September 2020 in three UK tertiary centres. Primary outcome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanner, Alexander, Haddad, Fadi, Fajardo-Sanchez, Julia, Nguyen, Ethan, Thong, Kai Xin, Ah-Moye, Sarah, Perl, Nicole, Abu-Bakra, Mohammed, Kulkarni, Avinash, Trikha, Sameer, Lascaratos, Gerassimos, Parnell, Miles, Kailani, Obeda, King, Anthony J, Agrawal, Pavi, Stead, Richard, Giannouladis, Konstantinos, Rodrigues, Ian, Goyal, Saurabh, Hysi, Pirro G, Lim, Sheng, Yu-Wai-Man, Cynthia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359526/ https://www.ncbi.nlm.nih.gov/pubmed/35365491 http://dx.doi.org/10.1136/bjophthalmol-2021-320631

Ejemplares similares

PreserFlo MicroShunt® exposure: a case series
por: Bunod, Roxane, et al.
Publicado: (2021)

PreserFlo™ MicroShunt Combined with Phacoemulsification versus PreserFlo™ MicroShunt as a Standalone Procedure in Patients with Medically Resistant Open-Angle Glaucoma
por: Fili, Sofia, et al.
Publicado: (2022)

PreserFlo Microshunt for the management of intraocular pressure elevation in iridocorneal endothelial syndrome
por: Ruparelia, Sunil, et al.
Publicado: (2023)

Dislocation of the PreserFlo MicroShunt During a Postsurgical Needling Procedure
por: Murakami, Kana, et al.
Publicado: (2023)

PreserFlo(®) MicroShunt: An Overview of This Minimally Invasive Device for Open-Angle Glaucoma
por: Gambini, Gloria, et al.
Publicado: (2022)

The PreserFlo MicroShunt in the Context of Minimally Invasive Glaucoma Surgery: A Narrative Review
por: Saeed, Emil, et al.
Publicado: (2023)

Outcomes of Open Bleb Revision After PreserFlo MicroShunt Failure in Patients With Glaucoma
por: Strzalkowska, Alicja, et al.
Publicado: (2023)

Intraoperative primary partial occlusion of the PreserFlo MicroShunt to prevent initial postoperative hypotony
por: Lüke, Jan Niklas, et al.
Publicado: (2023)

Early evaluation of optic nerve head morphology and choroidal thickness after PreserFlo MicroShunt implantation
por: Gambini, Gloria, et al.
Publicado: (2022)

Inter-eye relationship of intraocular pressure change after unilateral trabeculectomy, filtering canaloplasty, or PreserFlo™ microshunt implantation
por: Aghayeva, Fidan A., et al.
Publicado: (2021)

A comparison of iStent combined with phacoemulsification and endocyclophotocoagulation (ICE2) with the PreserFlo MicroShunt and XEN-45 implants
por: Qidwai, Umair, et al.
Publicado: (2022)

Early post-operative anterior segment parameters modifications induced by PreserFlo MicroShunt in primary open-angle glaucoma
por: Gambini, Gloria, et al.
Publicado: (2023)

Efficacy and Safety of PreserFlo(®) MicroShunt After a Failed Trabeculectomy in Eyes with Primary Open-Angle Glaucoma: A Retrospective Study
por: Quaranta, Luciano, et al.
Publicado: (2021)

Detailed intraocular pressure curve by telemetric tonometry with an implanted pressure sensor before and after PreserFlo(®) MicroShunt implantation: a case report
por: Gassel, Caroline Julia, et al.
Publicado: (2023)

Anterior Segment-Optical Coherence Tomography Bleb Morphology Comparison in Minimally Invasive Glaucoma Surgery: XEN Gel Stent vs. PreserFlo MicroShunt
por: Gambini, Gloria, et al.
Publicado: (2022)

PreserFlo™ MicroShunt Versus Trabeculectomy in Patients With Moderate to Advanced Open-Angle Glaucoma: 12-Month Follow-Up of a Single-Center Prospective Study
por: Fili, Sofia, et al.
Publicado: (2022)

Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation
por: Vastardis, Iraklis, et al.
Publicado: (2021)

PreserFlo™ MicroShunt Versus Ab Externo Canaloplasty in Patients With Moderate to Advanced Open-Angle Glaucoma: 12-Month Follow-Up of a Single-Center Retrospective Study
por: Habbe, Kirsten Julia, et al.
Publicado: (2023)

Mitomycin: Trans-conjunctival erosion of Preserflo microshunt: case report
Publicado: (2021)

Evaluation of the Ultrastructural and In Vitro Flow Properties of the PRESERFLO MicroShunt
por: Barberá, Marta Ibarz, et al.
Publicado: (2021)

Conjunctival erosion following a PRESERFLO® MicroShunt procedure
por: Fahy, Eamonn T., et al.
Publicado: (2022)

A New and Easier Approach to Preserflo MicroShunt Implantation
por: Fea, Antonio M, et al.
Publicado: (2022)

Efficacy of the PRESERFLO MicroShunt and a Meta-Analysis of the Literature
por: Pawiroredjo, Shigeo S. M., et al.
Publicado: (2022)

Insertion of a Preserflo microshunt inside a non-valved glaucoma shunt to treat late-onset hypotony
por: Malick, Huzaifa, et al.
Publicado: (2022)

Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma
por: Ibarz Barberá, Marta, et al.
Publicado: (2022)

Safety and Efficacy of the Preserflo(®) Microshunt in Refractory Glaucoma: A One-Year Study
por: Majoulet, Alexandre, et al.
Publicado: (2022)

PRESERFLO ™ MicroShunt versus trabeculectomy: 1-year results on efficacy and safety
por: Jamke, Melanie, et al.
Publicado: (2023)

Bleb geometry and morphology after Preserflo Microshunt surgery: Risk factors for surgical failure
por: Ibarz Barberá, Marta, et al.
Publicado: (2023)

Long-Term Outcomes of the PRESERFLO MicroShunt Implant in a Heterogeneous Glaucoma Cohort
por: Storp, Jens Julian, et al.
Publicado: (2023)

Clinical outcomes of combined Preserflo Microshunt implantation and cataract surgery in open-angle glaucoma patients
por: Martínez-de-la-Casa, José M., et al.
Publicado: (2021)

One-Year Outcomes of Preserflo(TM) MicroShunt Implantation versus Trabeculectomy for Pseudoexfoliation Glaucoma
por: Nobl, Matthias, et al.
Publicado: (2023)

Comparison of Bleb Morphology following PRESERFLO(®) MicroShunt and Trabeculectomy Using Anterior Segment OCT
por: Hasan, Somar M., et al.
Publicado: (2023)

Endothelial cell loss 5 years after Preserflo MicroShunt implantation: About two cases
por: Chamard, Chloé, et al.
Publicado: (2021)

Short-term safety and efficacy of Preserflo™ Microshunt in glaucoma patients: a multicentre retrospective cohort study
por: Bhayani, Raj, et al.
Publicado: (2022)

Expert Consensus on the Use of the PRESERFLO™ MicroShunt Device in the Treatment of Glaucoma: A Modified Delphi Panel
por: Khawaja, Anthony P., et al.
Publicado: (2022)

Correction to: Expert Consensus on the Use of the PRESERFLO™ MicroShunt Device in the Treatment of Glaucoma: A Modified Delphi Panel
por: Khawaja, Anthony P., et al.
Publicado: (2022)

Early Complications and Results of Preserflo MicroShunt in the Management of Uncontrolled Open-Angle Glaucoma: A Case Series
por: Saeed, Emil, et al.
Publicado: (2022)

Preserflo Microshunt Surgery for Ocular Hypertension following Intravitreal Fluocinolone Acetonide Implant Removal: A Case Report
por: Rezkallah, Amina, et al.
Publicado: (2022)

Systematic Preserflo MicroShunt Intraluminal Stenting for Hypotony Prevention in Highly Myopic Patients: A Comparative Study
por: Lupardi, Enrico, et al.
Publicado: (2023)

Will the PRESERFLO™ MicroShunt impact the future of trabeculectomy practice? A UK and Éire Glaucoma Society National Survey
por: Kuet, Mong-Loon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ojk4ab6o0ja0cdu6p55o9187i2